Task: Answer the multiple choice question.
Query: Which compound exhibits a -2.848\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) Cc1ccc(-c2c3c(=O)n(C)c(=O)n(C)c3cn2Cc2ccccc2)cc1
b.) C=CCNC(=O)CN1N=C(c2ccc(C)cc2)CCC1=O
Answer: b. C=CCNC(=O)CN1N=C(c2ccc(C)cc2)CCC1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C=CCNC(=O)CN1N=C(c2ccc(C)cc2)CCC1=O
C=CCNC(=O)CN1N=C(c2ccc(C)cc2)CCC1=O
2-[3-(4-methylphenyl)-6-oxo-4,5-dihydropyridazin-1-yl]-N-prop-2-enylacetamide